echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The first domestic product! First in class small molecule MIF inhibitor application for clinical application

    The first domestic product! First in class small molecule MIF inhibitor application for clinical application

    • Last Update: 2021-11-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Info

    On September 26, the official website of the Center for Drug Evaluation (CDE) of the State Food and Drug Administration showed that the clinical application of Amifi Bio-targeted MIF small molecule inhibitor IPG1094 tablets was accepted by the State Food and Drug Administration


    Macrophage migration inhibitory factor (MIF) is the only cytokine with enzymatic activity.


    MIF inhibitors can not only directly inhibit the growth of tumor cells, but can also reverse the tumor immunosuppressive microenvironment by inhibiting the generation of MDSC, and have dual anti-tumor functions


    IPG094 is independently developed by Aimefel Biosciences.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.